- Acne
- Addiction
- Allergy
- Anti-infectives
- BPH
- Cardiovascular Disorder
- Dermatological Disorder
- Diabetes
- Dyslipidemia
- Ebola Virus Disease
- Gastrointestinal Disorder
- Headache
- Hepatitis
- Hypertension
- Infection Prevention & Control
- Infections
- Influenza
- Inhalation Devices
- Kidney & Urinary Tract
- Malaria
- Medico-Legal
- Musculoskeletal Disorder
- Neurological Disorder
- Respiratory Tract Disorder
Webcasts
Our Publications
Key Trials
Patient Education
Clinical Tools
Patient Education
Webcasts
Expert's Viewpoint
Our Publications
- Intranasal Steroids for Allergic Rhinitis: A Guide for Practitioners
- Inhalation Devices: Guide for Paramedics
- Allergic Rhinitis- From Beginning to End
- Allergic Rhinitis and Rhinosinusitis: The Link
- Allergy Express: Issue 3
- Bronchonasal Crosstalk
- Nickel Allergies Due to Mobile Phones: Allusion to Practice
- Minimal Persistent Inflammation in Allergic Rhinitis
- ARIA 10' Guidelines Booklet
Key Trials
- Fluticasone is Comparable to Mometasone in Alleviating Symptoms of Allergic Rhinitis
- Montelukast Combined with Antihistaminics Might Benefit Patients with Resistant Allergic Rhinitis
- Rapid Onset of Action of Azelastine hydrochloride and Fluticasone propionate Combination Nasal Spray
- Efficacy and Superiority of Intranasal Azelastine and Fluticasone Combination Spray as Compared to Monotherapy in Allergic Rhinitis
- In AR, Montelukast-Fexofenadine Offers Superior Efficacy at a Higher Cost than Montelukast-Levocetirizine
- Bilastine Safe in Elderly Patients with Allergic Rhinoconjunctivitis and/or Urticaria
- Intranasal Spray Containing Azelastine Hydrochloride and Fluticasone Propionate Offers Rapid Symptom Relief in Seasonal Allergic Rhinitis
- Bilastine Effective and Safe in Perennial Allergic Rhinitis: A Japanese Phase 3 Study
- Self-Prepared Hypertonic Nasal Saline Irrigation Alleviates Nasal Congestion and Improves Quality of Life in Allergic Rhinitis
- Determining the Efficacy of Bilastine in Japanese Cedar Pollinosis using an OHIO Chamber
- Intranasal Spray Containing Azelastine hydrochloride and Fluticasone propionate is Safe and Well Tolerated in Children with Allergic Rhinitis
Patient Education
Webcasts
- Role of Fosfomycin IV in VAP, Sepsis and Bacterial Meningitis Patients
- Walking the Narrow Path: The Fine Line “Role of Fosfomycin IV in VAP, Sepsis and cUTI Patients
- CLSI 2020 Updates
- Dealing with Complicated UTI to Urosepsis in the era of Antibiotic Resistance: Case based Discussion on role of Ceftriaxone Sulbactam EDTA
- A Case-based Discussion on Role of Fosfomycin IV in VAP and Sepsis
- Art of Prescribing Antifungals
- Optimizing the use of Colistin in an Era of MDR Infections
- Time Series Analysis of Antibiotic Resistance at a Tertiary Care Hospital & Community in Delhi
- Colistin in Carbapenem Resistant Infections Experience from an Indian Centre
- Antibiotic Stewardship – A Must Do in the Era of Antibiotic Resistance (Panel Discussion)
- Judicious Use of Antibiotics (2016)
- My Antibiotic Partner for Colistin
Expert's Viewpoint
- Experience sharing on Dose optimization of Minocycline Injection
- Webinar Snippet: Is the MIC of Minocycline Greater than 2? Time to Optimize Dose of Minocycline
- 3 reasons to Optimize the Dose of Minocycline
- Webinar Snippet: Can Minocycline be Used Against CRE and at What Dose?
- Webinar Snippet: Can Minocycline be Given as a Monotherapy?
- Webinar Snippet: Is Minocycline Safe to Use?
- Webinar Snippet: Does Minocycline Score Over Colistin?
- Webinar Snippet: Why Tigecycline Not Recommended in Blood Stream Infection?
- Webinar Snippet: Why High Dose Minocycline Should be Used?
- Use of Flucytosine Tablets with Key Principles for Safely of Patients
Our Publications
Key Trials
- Colistin & β-lactams – No Significant Difference in Nephrotoxicity Study
- Ceftriaxone, Sulbactam and Disodium EDTA Combination Therapy Might Spare Carbapenems in Management of Multidrug Resistant Nosocomial Infections
- Tinidazole versus Metronidazole in Treatment of Amoebic Liver Abscess
- Remdesivir Shortens Time to Recovery in Patients Hospitalized with COVID-19
- 3-day Treatment with Azithromycin (10 mg/kg per day once daily), A Promising Alternative Therapy for Tonsillitis in Children
- Noninferiority of Ceftriaxone, Sulbactam, and Disodium EDTA to Meropenem in Complicated UTIs
- Efficacy of High Dose Minocycline against Carbapenem Resistant Gram Negative Bacilli
- Tigecycline Monotherapy vs. Imipenem/Cilastatin in Hospitalized Chinese Patients with cIAIs
- TARGET Workshops Resources Improved Antibiotic Dispensing in Primary Care
Webcasts
Expert's Viewpoint
- Experts’ Bytes on BPH: Duration of Prescription for Alpha Blocker Monotherapy and Alpha Blocker-5ARI Combination Therapy.
- Experts’ Bytes on BPH: Lifestyle Modification Tips for Patients with LUTS due to BPH
- Experts’ Bytes on BPH: Importance of Taking Medical History in LUTS
- Experts’ Bytes on BPH: Prevalence of LUTS in General Population
- Experts’ Bytes on BPH: Causes of LUTS other than BPH
- Experts’ Bytes on BPH: What is the general protocol for following up with patients with BPH or LUTS? Which investigation is to be repeated and how often?
- Experts’ Bytes on BPH: In our daily practice we get geriatric patients. Do you recommend the Serum PSA test to these regular patients not suffering from LUTS rather coming for a problem related to neurological, cardiological etc?
- Experts’ Bytes on BPH: If Patient Coming with Fever Has Some Symptoms but Urine Doesn’t Show Anything, How Do You Approach Them in Making the Diagnosis?
- Experts’ Bytes on BPH: In Addition to The Management Of OAB, Do We Need to Check the Urine Flow Through Uroflowmetry Test and PVR Volume Through Abdominal Ultrasound?
- Experts’ Bytes on BPH: How to manage Overactive Bladder or Bothered Storage Symptoms?
- Experts’ Bytes on BPH: How to Approach the Status Post Prostatectomy with LUTS?
- Experts’ Bytes on BPH: How Long Should We Continue Drugs for LUTS?
Key Trials
- Efficacy Evaluation of Solifenacin and Tamsulosin Combination Therapy vs. Tamsulosin Monotherapy
- Silodosin, An Efficacious and Safe Drug for Relief from Nocturia Due to BPH
- Post-Marketing Surveillance of Silodosin in Patients with Benign Prostatic Hyperplasia and Unsatisfactory Response to Initial Αlpha1 Blocker Therapy: The SPLASH Study
- Tamsulosin Reduces Night Time Urine Production in Nocturnal Polyuria Due to BPH: A Single-Arm, Open-Label, Prospective Study
__07.10.2020.jpg)
Webcasts
Expert's Viewpoint
- NYHA & ACCF Classification of Heart Failure & Assessment of Patient at the Bed Side
- How to Manage Heart Failure?
- What is Heart Failure and Clinical Presentation of Heart Failure
- How to Evaluate and Diagnose Heart Failure?
- Cardiac Cycle and Measures of Cardiac Functions
- Global Trends in Heart Failure – Issue 5 Q9
- Global Trends in Heart Failure – Issue 5 Q8
- Global Trends in Heart Failure – Issue 5 Q7
- Global Trends in Heart Failure – Issue 5 Q5
- Global Trends in Heart Failure – Issue 5 Q4
- Global Trends in Heart Failure – Issue 5 Q3
- Global Trends in Heart Failure – Issue 5 Q2
- Global Trends in Heart Failure – Issue 5 Q1
- Global trends in Heart Failure – Issue 4: Q5
- Global trends in Heart Failure – Issue 4: Q4
- Global trends in Heart Failure – Issue 4: Q6
- Global trends in Heart Failure – Issue 4: Q3
- Global trends in Heart Failure – Issue 4: Q2
- Global trends in Heart Failure – Issue 4: Q1
- Webinar Snippet: Treatment Preference: Line Of Treatment For Stage 2 & 3 HTN
- Webinar Snippet: Undesirable Combinations In HTN Management
- Webinar Snippet: Combination Therapy In HTN: Rationale And Benefits
- Webinar Snippet: Pharmacotherapy: First Line Drugs For HTN Management
- Webinar Snippet: Goal Of HTN Management
- Webinar Snippet: BP Threshold In CAD: BP Threshold And Target Goal In CAD Patient
- Webinar Snippet: CV Risk Assessment: Available Tools For CV Risk Assessment.
- Webinar Snippet: CV Risk Factors: Factors Influencing CV Disease, Mortality And Morbidity
- Evaluation Of HTN- What Should Be The Objective Behind Evaluation Of HTN?
- Webinar Snippet: ABPM: Important Points About ABPM
- Webinar Snippet: Out Of Office BP: Rationale Behind Out Of Office Blood Pressure Monitoring
- Webinar Snippet: BP Cut Off Values: BP Cut Off Values By Different Guidelines
- Webinar Snippet: Diagnosis Of HTN: Available Methods For Diagnosis Of HTN
- Webinar Snippet: Screening Of HTN: Key Precautions To Be Taken In BP Measurement
- Webinar Snippet: Epidemiology: Prevalence Of Uncontrolled Hypertension
- Webinar Snippet: Case Presentation: Rescue Act by Mexiletine in VT/VF Storm Post PCI
- Webinar Snippet: Role of Mexiletine as Anti-Arrhythmic Agent
- Webinar Snippet: Is ‘Mexiletine’ First Drug of Choice in the Management of VT?
- Webinar Snippet: What is the Recommended Dosage of Mexiletine?
- Global trends in Heart Failure – Issue 3: Q3
- Global trends in Heart Failure – Issue 3: Q2
- Global trends in Heart Failure – Issue 3: Q1
- Global Trends in Heart Failure – Issue 2: Q9
- Global Trends in Heart Failure – Issue 2: Q8
- Global Trends in Heart Failure – Issue 2: Q7
- Global Trends in Heart Failure – Issue 2: Q6
- Global Trends in Heart Failure – Issue 2: Q5
- Global Trends in Heart Failure – Issue 2: Q4
- Global Trends in Heart Failure – Issue 2: Q3
- Global Trends in Heart Failure – Issue 2: Q2
- Global Trends in Heart Failure – Issue 2: Q1
- Global Trends in Heart Failure – Issue 1: Q7
- Global Trends in Heart Failure – Issue 1: Q6
- Global Trends in Heart Failure – Issue 1: Q5
- Global Trends in Heart Failure – Issue 1: Q4
- Global Trends in Heart Failure – Issue 1: Q3
- Global Trends in Heart Failure – Issue 1: Q2
- Global Trends in Heart Failure – Issue 1: Q1
- New Generation Thrombolytic to Optimize STEMI Care
Our Research
Key Trials
- Coadministration of Telmisartan/amlodipine and Rosuvastatin Safe and Effective in Hypertensive Patients with Dyslipidemia
- Long-term Impact of CVD and CKD on Life Expectancy and on Direct Medical Costs in Patients with Diabetes
- OPTIMISE Trial: Impact of Antihypertensive Medication Reduction in Elderly Hypertensive Patients
- Identifying Atrial Fibrillation Patients using Smartwatch App Detected Pulse Irregularities
- Azilsartan is Superior to Olmesartan in Hypertensives with Type 2 Diabetes/ Prediabetes
- HOPE-3: Lowering BP and LDL-Cholesterol Lowers the Risk of CV Events in Individuals without CVD
- HOPE 3: Long-term Cholesterol Lowering with Low-dose Rosuvastatin Alleviates CV Risk in Intermediate-Risk Multi-Ethnic Population
- SPRINT: Intensive BP lowering Superior in Terms of Lowering CV Events & Death vs. Standard BP lowering in High-Risk Patients without Diabetes
Patient Education
Clinical Tools
- Importance of Food Choices to Lower Low-Density Lipoprotein Cholesterol and Improve the Overall Lipoprotein Profile
- Impact of Specific Lifestyle Changes on Lipid Levels
- Role of Lipid Analyses for CV Disease Risk Estimation-ESC 2019-Lipid Guidelines
- Intervention Strategies as A Function of Total CV Risk and Untreated LDL Levels: ESC 2019 Lipid Guidelines
- Cardiovascular Risk Categories: ESC 2019 Lipid Guidelines
- The Healthy Heart Score: Cardiovascular Health Calculator
.jpg)
Guidelines
- USPSTF: Screening for Hypertension in Adults (2021)
- ISH: Global Guideline on Hypertension (2020): How to Measure Blood Pressure Correctly?
- ISH: Global Guideline on Hypertension (2020): Lifestyle Modifications for the Management of Hypertension
- ISH: Management of Hypertension in Adults (2020)
- ISH: Optimal Recommendations for Hypertension (2020)
- ISH: Essential Recommendations for Hypertension (2020)
- NICE: Diagnosis and Management of Hypertension (2019)
- ESH/ESC: Management of Arterial Hypertension (2018)
- ESC: Diagnosis and Management of Syncope (2018)
- AHA/ACC/HRS: Guideline for Management of Patients with Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death (2017)
- ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA: Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults (2017)
- ADA: Diabetes and Hypertension - Position Statement (2017)
- ACC/AHA/HFSA: Management of Heart Failure-Focused Update of the 2013 Guidelines (2017)
- AACE/ACE: Management of Dyslipidemia and Prevention of Cardiovascular Diseases (2017)
- ACC/AHA/HRS: Evaluation and Management of Patients with Syncope (2017)
- AHA: Meal Timing and Frequency for Prevention of Cardiovascular Diseases-A Scientific Statement (2017)
- ACP/AAFP: Pharmacological Management of Hypertension in Elderly (>60 years) (2017)
- AHA: Implementation of Telehealth in Cardiovascular and Stroke Care (2016)
- NOF/ASPC: Role of Calcium with or without Vitamin D for the Management of CVD (2016)
- AHA: Impact of Hypertension on Cognitive Function (2016)
- AHA: Sedentary Behavior and Cardiovascular Morbidity and Mortality - A Scientific Advisory (2016)
- Cardiovascular Care in College Athletes - Expert Consensus and Guidelines (2016)
- AHA: Scientific Statement on Drugs that May Cause or Exacerbate Heart Failure (2016)
- USPSTF: Use of Aspirin for the Primary Prevention of Cardiovascular Disease and Colorectal Cancers (2016)
- AHA/ASA: Prevention of Stroke in Women (2014)
- Panel of JNC 8: Management of High Blood Pressure (2014)
- ASH/ISH: Clinical Practice Guidelines for the Management of Hypertension (2014)
- AHA: Ambulatory Blood Pressure Monitoring in Children and Adolescents – A Scientific Statement (2014)
- IGH: Indian Guidelines on Hypertension (2013)
- AHA: Prevention of Cardiovascular Disease in Women (2011)
- ACCF/AHA: Hypertension in the Elderly - Expert Consensus (2011)
- NICE: Clinical Management of Primary Hypertension (2011)
Webcasts
Our Publications
Clinical Tools
Our Publications
Our Research
Key Trials
- Comparative Effectiveness of Various Classes of Antihyperglycemic Agents on Risk of Kidney Outcomes: Real-world Evidence
- Impact of Glucose-lowering Drugs or Strategies on CV Events in Individuals with or at Risk of T2DM
- CANVAS Program: Impact of Canagliflozin on Cardiovascular and Renal Outcomes in Type-2 Diabetes Patients
- Effectiveness of Integrated Personalised Diabetes Care with Digital Therapeutics to Improve Glycemic Control in T2DM Patients
- The Omega Study: Benefit of Vildagliptin/Metformin addition to T2DM Patients Uncontrolled on Insulin
- Scandinavian Cohort Study: Ascertaining the Renoprotection rendered by SGLT2 Inhibitors in the Real World
- VERIFY: Early Vildagliptin and Metformin Combination Therapy Associated with Greater and Long-term Glycemic Durability vs. Metformin Monotherapy
- Impact of Cadexomer Iodine on Microbial Population of Chronic non-healing DFUs Complicated by Biofilm
- Moderate Weight Loss following Diabetes Diagnosis May Reduce Long-term CVD Risk
- Sustained Reduction in Incident Diabetes Even 3 Years after Withdrawal of Active SMS-based Lifestyle Intervention
- Impact of Diabetes on Kidney Function Decline: Results from A 26-year Follow up of Community-based Cohort
- Preservation of Beta-cell Function: Daily Metformin vs. Intermittent Intensive Insulin Therapy
- Benefits of Initial Combination Therapy of Vildagliptin/Metformin in Asian T2DM Patients
- Azilsartan is Superior to Olmesartan in Hypertensives with Type 2 Diabetes/ Prediabetes
- Prevalence of Diabetes and Prediabetes in 15 States of India: Insights from the ICMR–INDIAB Population-Based Study
- Poorly Controlled Diabetes – Strongest Predictor for Mortality Due to Renal Failure Among Indians: Insights from The Million Death Study
- Early Treatment during Prediabetes Improves Clinical Outcomes and Lowers Healthcare Costs
- Effectiveness and Cost-effectiveness of Benefit-based Treatment vs. Treat-to-target Treatment in Type-2 Diabetes
Patient Education
Clinical Tools
Guidelines
- NICE: An Update on Diagnosis and Management of Diabetes (Type-1 and Type-2) in Children and Young People (2020)
- AHA: Novel Therapies for Cardiovascular Risk Reduction in Patients with Type 2 Diabetes (2020)
- NICE: The Diagnosis and Management of Type 1 Diabetes in Adults - An Update (2020)
- RSSDI-ESI: Clinical Practice Recommendations for the Management of Type-2 Diabetes Mellitus (2020)
- ADA/EASD: Management of Hyperglycemia in Type-2 Diabetes Mellitus-An Update (2019)
- NICE: Prevention and Management of Diabetic Foot Problem (2019)
- NICE: Management of Type-2 Diabetes Mellitus in Adults (2019)
- ESC/EASD: Guidelines on Diabetes, Prediabetes and Cardiovascular Disease (2019)
- ADA/EASD: Standards of Medical Care in Diabetes (2019)
- ADA: Evaluation and Management of Youth-onset Diabetes (2018)
- IDF: Management of Diabetic Foot (2017)
- ADA Recommendations: Diabetic Kidney Disease (2017)
- ADA Recommendations: Diagnosis & Management (2017)
- ACP: Oral Pharmacologic Treatment of Type-2 Diabetes Mellitus (2017)
- ADA: Standard of Medical Care in Diabetes (2017)
- IDF: Management of Diabetes during Ramadan (2016)
- AACE/ACE: Outpatient Glucose Monitoring Consensus Statement (2016)
- AHA/ADA: Update on Prevention of Cardiovascular Disease in Adults with Type 2 Diabetes Mellitus (2015)
- ADA/EASD: Management of Hyperglycemia in Type 2 Diabetes, a Patient-centered Approach: Update to a Position Statement (2015)
- AACE/ACE: Comprehensive Diabetes Management Algorithm (2015)
- ADA: Nutrition Therapy Recommendations for the Management of Adults with Diabetes: Position Statement (2013)
- ACSM/ADA: Exercise and Type 2 Diabetes: Joint Position Statement (2010)
-02.jpg)
Webcasts
Our Publications
- The Changing Landscape of CV Risk Reduction - Is LDL Lowering Sufficient: Questions & Answers (Dr. Michael Miller, USA)
- Newer Perspectives in Lipid Management: Questions & Answers (Dr. Harold Bays, USA)
- Newer Perspectives in Statin Therapy: Questions & Answers (Dr. Michael Davidson, USA)
- Atherogenic Dyslipidemia: Questions and Answers (Dr Abhimanyu Garg, USA)
- Dyslipidemia (Essence Series)
Our Research
Key Trials
- Coadministration of Telmisartan/amlodipine and Rosuvastatin Safe and Effective in Hypertensive Patients with Dyslipidemia
- HOPE-3: Lowering BP and LDL-Cholesterol Lowers the Risk of CV Events in Individuals without CVD
- HOPE 3: Long-term Cholesterol Lowering with Low-dose Rosuvastatin Alleviates CV Risk in Intermediate-Risk Multi-Ethnic Population
- ACCORD Eye: Impact of Intensive Treatment Strategies on Progression of Retinopathy in Type-2 Diabetes Mellitus Patients
- ACCORDION: Eye Benefits due to Intensive Glycemic Control Persist even 4 Years after Treatment Discontinuation
- SPARCL (Stroke Prevention by Aggressive Reduction in Cholesterol Levels)
- CAPISH (Conversion to Atorvastatin in Patients Intolerant or Refractory to Simvastatin Therapy)
- ROMA (Reduce the Incidence of MyocArdial Periprocedural Necrosis)
- IDEAL (Incremental Decrease in End Points Through Aggressive Lipid Lowering) Study
- CLARIDI Study (Cholesterol Lowering and Arrhythmia Recurrences after Internal Defibrillator Implantation)
- TNT (Treating to New Targets) Trial
- ALLIANCE (Analysis of Aggressive Lipid-Lowering Initiation Abates New Cardiac Events)
- CARDS Study (Collaborative Atorvastatin Diabetes Study)
Clinical Tools
- Importance of Food Choices to Lower Low-Density Lipoprotein Cholesterol and Improve the Overall Lipoprotein Profile
- Impact of Specific Lifestyle Changes on Lipid Levels
- Role of Lipid Analyses for CV Disease Risk Estimation-ESC 2019-Lipid Guidelines
- Intervention Strategies as A Function of Total CV Risk and Untreated LDL Levels: ESC 2019 Lipid Guidelines
- Cardiovascular Risk Categories: ESC 2019 Lipid Guidelines
Guidelines
- Heart UK: Management of Children and Young People with Heterozygous Familial Hypercholesterolemia (2019)
- ESC: Management of Dyslipidemia (2019)
- ACC/AHA/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA: Management of Blood Cholesterol (2018)
- ACC: Role of Non-Statin Therapies for LDL-Cholesterol Lowering in the Management of Atherosclerotic Cardiovascular Disease Risk-Expert Consensus: Focused Update (2017)
- USPSTF: Use of Statins for the Primary Prevention of Cardiovascular Disease (2016)
- AHA: Management of Clinically Significant Drug Interactions with Statins and Select Agents Used in CVD (2016)
- NICE: Cardiovascular Risk Assessment and the Modification of Blood Lipids for the Primary and Secondary Prevention of Cardiovascular Disease- An Update (2016)
- ACC: Role of Non-Statin Therapy for Lowering LDL-Cholesterol in the Management of Atherosclerotic Cardiovascular Risk-Expert Consensus (2016)
- KDIGO: Lipid Management in Chronic Kidney Disease (2013)
- ACC/AHA: Treatment of Blood Cholesterol to Reduce Atherosclerotic Cardiovascular Risk in Adults (2013)
- NIH: Detection, Evaluation, and Treatment of High Blood Cholesterol – ATP III: An Update (2013)
- NFK KDOQI: Managing Dyslipidemias in Chronic Kidney Disease (2003)
Our Publications
Patient Education
Webcasts
Our Publications
Key Trials
- Zinc: Low Dose vs. High Dose for Childhood Diarrhoea
- Greater Patient Satisfaction After Switching to Esomeprazole in Gastro-oesophageal Reflux Disease
- Esomeprazole Achieves Relief of Nighttime Heartburn and Improves Sleep Quality in GERD
- L Rhamnosus GG Reduced Duration of Diarrhoea In Children with Acute Gastroenteritis: Result of A Meta-Analysis
- Short Term Proton Pump Inhibitor Use Can Increase Risk of Hip Fracture in Elderly Alzheimer Patients
- High or Low Dose Proton Pump Inhibitors, With or Without Diuretics, Do Not Cause Hypomagnesemia
- Impact of Polyethylene Glycol Treatment on Children with Constipation
Patient Education
Guidelines
- BSG: Management of Irritable Bowel Syndrome (2021)
- ACG Guideline: Management of Dyspepsia (2017)
- Maastricht V/Florence Consensus: Management of Helicobacter pylori Infection (2016)
- AGA: Constipation: Medical Position Statement (2014)
- ACG: GERD: Guideline Top Recommendations (2013)
- ACG: Diagnosis and Management of GERD: Guideline Summary (2013)
- WGO: Acute Diarrhea: Practice Guidelines (2012)
- World Gastroenterology Organization Practice Guidelines for the Diagnosis and Management of IBD (2010)
- ACG: Ulcerative Colitis: Practice Guidelines (2010)
Expert's Viewpoint
Our Publications
Key Trials
Conference Proceedings
Patient Education
Guidelines
- IHS: Health Technology Assessment for the Acute and Preventive Treatment of Migraine (2021)
- AAN/AHS: Acute Treatment of Migraine in Children and Adolescents - An Update (2019)
- AAN/AHS: Pharmacologic Treatment for Pediatric Migraine Prevention (2019)
- AAN & AHS: Guidelines for the Pharmacologic Prevention of Episodic Migraine in Adults: An Update (2019)
- BASH: Management of Headache in Adults (2019)
- AHS: Position Statement on Integrating New Migraine Treatment into Clinical Practice (2019)
- International Classification of Headache Disorders-3rd Edition (2018)
- NICE: Diagnosis and Management of Headaches in Patients Aged above 12 years-An Update (2015)
- IHS: Guideline on Headache Classification (2013)
- BASH: Guidelines for the Diagnosis and Management of Migraine, Tension-Type headache, Cluster Headache & Medication Overuse Headache (2010)
- EFNS: Guidelines on the Drug Treatment of Migraine: Report (2009)
- SIGNS: Guidelines for the Diagnosis and Management of Headache in Adults (2008)
Our Publications
- Approach to Hepatitis B in Pregnancy
- HCV Management Series: Management of Treatment-naïve and Treatment-experienced HCV Patients
- HCV: Epidemiology, Screening and Diagnosis
- Managing Treatment Response and Resistance in Hepatitis B
- Tenvir (Tenofovir disoproxil fumarate) - Product Monograph
- Practice Guidelines for Chronic Hepatitis B
- Principles of Hepatitis B Treatment
- Evaluating a Patient with Hepatitis B
Key Trials
- Efficacy and Safety of Tenofovir Alafenamide in Chronic Hepatitis B Infection
- Long Term Efficacy and Safety of Tenofovir in Chronic Hepatitis B infection
- Maternal Use of Tenofovir: No Additional Benefit in Lowering Perinatal HBV Transmission
- Sofosbuvir - Velpatasvir FDC for HCV Genotypes 1 to 6 Infection – Integrated Analyses of ASTRAL Studies
- Efficacy of Tenofovir Alone in Hepatitis B Patients with Suboptimal Virologic Response to Adefovir
- Tenofovir Benefits Patients with Severe Reactivation of Hepatitis B
- Tenofovir May be Highly Effective in Chronic Hepatitis B Patients Who Fail to Respond to Lamivudine and Adefovir Therapy
- Entecavir Lowers the Incidence of Hepatocellular Carcinoma in HBV Infected Patients
- Long Term Treatment with Tenofovir Might Result in Regression of Cirrhosis in Patients with Chronic Hepatitis B infection
Conference Proceedings
Patient Education
Guidelines
Webcasts
- Current Trends in Hypertension Management
- Novel and Emerging Treatments for Hypertension
- Highlights of American Society of Hypertension Annual Scientific Meeting, 2015
- Hypertension Update 2014:Focus on New Guidelines
- Insights into JNC 2013 Guidelines, ASH and more...
- Hypertension: Challenges, Dilemmas and New Paradigms
- Recent Trends in Hypertension Management
Expert's Viewpoint
- Webinar Snippet: Treatment Preference: Line Of Treatment For Stage 2 & 3 HTN
- Webinar Snippet: Undesirable Combinations In HTN Management
- Webinar Snippet: Combination Therapy In HTN: Rationale And Benefits
- Webinar Snippet: Pharmacotherapy: First Line Drugs For HTN Management
- Webinar Snippet: Goal Of HTN Management
- Webinar Snippet: BP Threshold In CAD: BP Threshold And Target Goal In CAD Patient
- Webinar Snippet: CV Risk Assessment: Available Tools For CV Risk Assessment.
- Webinar Snippet: CV Risk Factors: Factors Influencing CV Disease, Mortality And Morbidity
- Evaluation Of HTN- What Should Be The Objective Behind Evaluation Of HTN?
- Webinar Snippet: ABPM: Important Points About ABPM
- Webinar Snippet: Out Of Office BP: Rationale Behind Out Of Office Blood Pressure Monitoring
- Webinar Snippet: BP Cut Off Values: BP Cut Off Values By Different Guidelines
- Webinar Snippet: Diagnosis Of HTN: Available Methods For Diagnosis Of HTN
- Webinar Snippet: Screening Of HTN: Key Precautions To Be Taken In BP Measurement
- Webinar Snippet: Epidemiology: Prevalence Of Uncontrolled Hypertension
Our Publications
Our Research
Key Trials
- ALLHAT Study: Worsening of Kidney Function-A Major Contributor of HF Risk in Hypertensives
- Coadministration of Telmisartan/amlodipine and Rosuvastatin Safe and Effective in Hypertensive Patients with Dyslipidemia
- OPTIMISE Trial: Impact of Antihypertensive Medication Reduction in Elderly Hypertensive Patients
- Azilsartan is Superior to Olmesartan in Hypertensives with Type 2 Diabetes/ Prediabetes
- Azilsartan is More Effective than Olmesartan in Reducing BP in Hypertensive Patients
- HOPE-3: Lowering BP and LDL-Cholesterol Lowers the Risk of CV Events in Individuals without CVD
- SPRINT: Intensive BP lowering Superior in Terms of Lowering CV Events & Death vs. Standard BP lowering in High-Risk Patients without Diabetes
- ONTARGET (Ongoing Telmisartan Alone and in Combination with Ramipril Global End-point Trial)
- ESPRIT (Efficacy & Safety in Patients with Renal Impairment treated with Telmisartan)
- ROADMAP (Randomized Olmesartan and Diabetes Microalbuminuria Prevention) Study
- PRISMA-II (Prospective, Randomised Investigation of the Safety and Efficacy of Telmisartan Versus Ramipril Using Ambulatory Blood Pressure Monitoring)
- SMOOTH (Study of Micardis in Overweight/Obese patients with Type-2 diabetes and Hypertension)
- PRISMA-I (Prospective, Randomised Investigation of the Safety and Efficacy of Telmisartan Versus Ramipril Using Ambulatory Blood Pressure Monitoring)
Patient Education
Guidelines
- USPSTF: Screening for Hypertension in Adults (2021)
- ISH: Global Guideline on Hypertension (2020): How to Measure Blood Pressure Correctly?
- ISH: Global Guideline on Hypertension (2020): Lifestyle Modifications for the Management of Hypertension
- ISH: Management of Hypertension in Adults (2020)
- ISH: Optimal Recommendations for Hypertension (2020)
- ISH: Essential Recommendations for Hypertension (2020)
- NICE: Diagnosis and Management of Hypertension in Pregnancy (2019)
- NICE: Diagnosis and Management of Hypertension (2019)
- ADA: Management of Hypertension in Diabetes-An Update (2018)
- ESH/ESC: Management of Arterial Hypertension (2018)
- ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA: Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults (2017)
- ADA: Diabetes and Hypertension - Position Statement (2017)
- ACP/AAFP: Pharmacological Management of Hypertension in Elderly (>60 years) (2017)
- AHA: Impact of Hypertension on Cognitive Function (2016)
- ASH/ISH: Clinical Practice Guidelines for the Management of Hypertension in the Community (2014)
- Panel of JNC 8: Management of High Blood Pressure (2014)
- AHA: Ambulatory Blood Pressure Monitoring in Children and Adolescents – A Scientific Statement (2014)
- API: Indian Guidelines on Hypertension – III (2013)
- ACCF/AHA: Hypertension in the Elderly - Expert Consensus (2011)
- NICE: Clinical Management of Primary Hypertension (2011)
- NFK KDOQI: Hypertension and Antihypertensive Agents in Chronic Kidney Disease (2004)
Webcasts
- A Case-based Discussion on Role of Fosfomycin IV in VAP and Sepsis
- Judicious use of Antibiotics (2017)
- Common Errors in Antimicrobial Therapy
- Judicious Use of Antibiotics (2016)
- Tropical Infections : A Case-based Approach
- Protecting Yourself (and your Patients) from Airborne Pathogens
- Drug Interactions – What Clinicians Need to Know?
- Vaccinations for Adults - What’s New, What Works?
- Pan Resistant Era: An SOS
- Infection Control in Health-Care Facilities: The Current Approach (Panel Discussion)
- If the Last Wall Falls…..The Need for Optimal use of Colistin
- Combating Influenza
- Optimizing the Use of Colistin in MDR Infections
Our Publications
Key Trials
Patient Education
Clinical Tools
Guidelines
- ATS: Nucleic Acid–based Testing for Noninfluenza Viral Pathogens in Adults with Suspected Community-acquired Pneumonia (2021)
- IDSA: Guidance on the Treatment of Antimicrobial Resistant Gram-Negative Infections (2020)
- IAP Guidebook on Immunization (2018–2019)
- CDC: Guideline for Surgical Site Infection Prevention (2017)
- NCDC: National Treatment Guidelines for Antimicrobial Use in Infectious Diseases (2016)
- NCDC: National Risk Communication Plan (2016)
- CDC: Updated Zika Recommendations: Interim Guidance for the Prevention of Sexually Transmitted Zika Virus (July, 2016)
- NCDC/WHO: Indian Public Health Legislations (2015)
- NCDC: National Guidelines on Diagnosis Case Management and Prevention and Control of Leptospirosis (2015)
- WHO: Guideline on When to Start Antiretroviral Therapy and on Pre-exposure Prophylaxis for HIV (2015)
- CDC: Pre-exposure Prophylaxis for the Prevention of HIV Infection – 2014 : A Clinical Practice Guideline (2014)
Webcasts
- A Case Based Discussion on Role of L-AMP in Immunocompromised Patients of Aspergillosis and Zygomycosis Infections
- Evolving Role of Anti-Virals in Mild to Moderate COVID-19
- Management of Urinary Tract Infection in Women
- REMDESIVIR: Evidence to Experience
- Complicated UTI & Urosepsis: Uro- Physician Perspectives
- Antibiotic Combinations Role of ARBs
- A Case of Swine Flu ARDS
- Walking the Narrow Path: The Fine Line “Role of Fosfomycin IV in VAP, Sepsis and cUTI Patients
- Dealing with Complicated UTI to Urosepsis in the era of Antibiotic Resistance: Case based Discussion on role of Ceftriaxone Sulbactam EDTA
- Optimization of High Dose Minocycline in Current MDR / XDR Era
- A Case-based Discussion on Role of Fosfomycin IV in VAP and Sepsis
- The Fine Line: Role of Fosfomycin IV in VAP and Sepsis Patients
- Spot Sepsis
- Optimizing the use of Colistin in an Era of MDR Infections
- Managing Critically Ill Patients with Polymyxin B: A Case Based Discussion
- Place in Therapy Of I.V Posaconzole In the Management of Invasive fungal infections in High-Risk Patients
- Acute Otitis Media: Case Based Approach
- Urinary Tract Infection in Children : How do I Investigate?
- Colistin and Polymyxin B: Peas in a Pod, or Chalk and Cheese?
- Herpetic Keratitis
- Judicious use of Antibiotics (2017)
- Dilemmas in the Management of Invasive Aspergillosis
- Serious Infections and their Mimics: Reading between the Lines
- Sepsis and ARDS: Which is the Chicken and Which is the Egg?
- From Laboratory to Clinic: The Importance of Correlating the Culture Reports with the Clinical Case
- Prevalence, Diagnosis and Management of Differential Fungal Infections
- Tuberculosis Management in the Era of Drug Resistance
- BPH & Comorbidities
- TB: Back with a Vengeance (Panel Discussion)
- My Antibiotic Partner for Colistin
- Fluids in Septic Shock
- The 4 W’s of Antifungals: Why, Whom, Which and When
- Hit Plasmodia Before it Gets Complicated
- Principles and Interpretations of Laboratory Diagnostics for Malaria, Dengue, Typhoid and Tuberculosis
- Lacunae in the Management of TB
- MDR/XDR TB: A Case Based Approach with Panel Discussion
Expert's Viewpoint
- Webinar Snippet: Is the MIC of Minocycline Greater than 2? Time to Optimize Dose of Minocycline
- Optimization of Tigecycline
- Webinar Snippet: Standard Management Protocol (Antibiotics/Prophylaxis/ Vaccine/Probiotics) & Cases Where Surgical Management is Needed
- Webinar Snippet: UTI in Diabetic Women - Case Illustrations
- Webinar Snippet: Assessment of UTI In Elderly Women
- Webinar Snippet: UTI in Elderly Women (Aging & Urinary Tract)
- Webinar Snippet: Pathophysiology & Predisposing Factors for UTI in Elderly Women
- Webinar Snippet: Fosfomycin in UTI – MOA, Dosage, Advantages & Place in Therapy
- Webinar Snippet: UTI & Its Recurrence in Pregnancy
- Webinar Snippet: Non-antibiotic Strategies for Prevention of UTI In Adolescent Girls and Females of Reproductive Age
- Webinar Snippet: Choosing an Antibiotic Treatment in Acute Uncomplicated Cystitis & Recurrent UTI In Adolescent Girls and Females of Reproductive Age
- Webinar Snippet: Acute Uncomplicated Cystitis in Adolescent Girls and Females of Reproductive Age – Diagnosis (History, Urine Analysis & Special Investigations)
- Management of Complicated UTI – A Case Discussion (Case 2)
- Management of Complicated UTI – A Case Discussion (Case 3)
- Experience Sharing of High Dose Minocycline by Infectious Disease Specialist
- Management of Complicated UTI – A Case Discussion
Our Publications
- Favipiravir: Frequently Asked Questions
- Ciplenza (Favipiravir) Monograph
- Cytorx (Flucytosine) Monograph
- Clarithromycin: An Emerging Treatment Recourse in Lower Respiratory Tract Infections
- Comprehensive Guide on the Use of Live Attenuated Influenza Vaccine (Nasovac-S)
- Zika Virus: A New Emerging Threat
- Guidance on Risk Categorization of Seasonal Influenza A H1N1 Cases during Screening
- Advisory for Vaccination and other Preventive Measures in Health Care Workers and General Public: Seasonal Influenza A (H1N1)
- Advisory for Families Staying and Travellers Visiting or Returning after Visiting Ebola-affected Countries
- Management of Ebola Virus Disease Patient in a Hospital
- An Overview of the Treatment Approaches Available for Ebola Virus Disease
- Summarized Clinical Practice Guidelines for the Diagnosis and Management of Group A Streptococcal Pharyngitis (Issue 2)
- H1N1: Guidance for Clinicians & Public Health Professionals
- H1N1: A Swine Flu Pandemic
Key Trials
- Efficacy, Safety and Adherence to Treatment of Mupirocin verses Fusidic Acid in Primary Impetigo
- Effects of Probiotic, Antibiotic or Combination on Intestinal Microbiota in Healthy Humans
- Clinical Outcomes of Amoxicillin–Clavulanate for 5 Days Verses 10 Days in Children with Acute Otitis Media
- Efficacy of Early Azithromycin Administration in Prevention of Severe LRTI in Children
- Intravenous Colistin Effective and Safe in Very Low Birth Weight Preterm Infants
- Fixed Dose Combination of Oral Cefixime and Moxifloxacin Improves Symptoms in Lower Respiratory Tract Infections
- Efficacy and Safety of Saccharomyces boulardii in Acute Childhood Rotavirus Diarrhoea
- Effect of Azithromycin Administration in Reducing the Risk of Subsequent Wheezing Episodes and Hospital Readmission in Infants with AB
- Efficacy of Saccharomyces boulardii verse Lactic Acid as Probiotics in Acute Paediatric Diarrhoea
- High Rates of Clinical Recovery with Remdesivir in Pregnant Women Hospitalized with Severe COVID-19
- Short-term Clinical and Bacteriological Efficacy and Safety of Ciprofloxacin for 7 Days versus 14 Days in Women with Acute Pyelonephritis
- Ceftriaxone, Sulbactam and Disodium EDTA Combination Effective Against E. coli Infections
- Cefpodoxime Safe and Effective in Empirical Treatment of Upper Respiratory Tract Infections
- Does Remdesivir Provide a Benefit on Clinical Status for Patients Hospitalized with Moderate COVID-19 Pneumonia?
- Remdesivir Improves Survival Outcomes in ICU Patients with COVID-19 under Mechanical Ventilation
- Efficacy and Safety of Remdesivir 5 Days Course verses 10 Days Course in Treatment of Patients with Severe Covid-19 Disease
- Ceftriaxone, Sulbactam and Disodium EDTA Combination Therapy Might Spare Carbapenems in Management of Multidrug Resistant Nosocomial Infections
- Efficacy of Daily Norfloxacin vs. Weekly Ciprofloxacin Prophylaxis for to Spontaneous Bacterial Peritonitis Prevention
- Tinidazole versus Metronidazole in Treatment of Amoebic Liver Abscess
- Remdesivir Shortens Time to Recovery in Patients Hospitalized with COVID-19
- Compassionate Use of Remdesivir to Treat Patients with Severe Covid-19
- Early Intervention with Remdesivir Associated with Clinical Improvement in Severe COVID-19 Patients
- Terbinafine versus Itraconazole in Treatment of Dermatophytic Infection of Skin
- Amoxicillin and Cefpodoxime Demonstrate Similar Clinical Efficacy in Children with Pneumonia
- Comparison of Standard-dose Versus High-dose of Amoxicillin/ Clavulanate for the Treatment of Clinically-diagnosed Acute Bacterial Sinusitis
- 3-day Treatment with Azithromycin (10 mg/kg per day once daily), A Promising Alternative Therapy for Tonsillitis in Children
- TANGO I Trial: Meropenem-Vaborbactam vs Piperacillin-Tazobactam for Treatment of Complicated Urinary Tract Infection
- Efficacy of Chlorhexidine in Reducing Oral Colonisation in the Geriatric Population
- Tigecycline Monotherapy vs. Imipenem/Cilastatin in Hospitalized Chinese Patients with cIAIs
- IDSA/ATS Guidelines Concerning Duration of Antibiotic Treatment Can be Safely Implemented Among Hospitalized Patients with CAP
- Amoxicillin versus Amoxicillin-Clavulanate Prophylaxis in the Removal of Third Molars
- Adjunctive Effect of the Metronidazole– Amoxicillin Antibiotic Combination in the Treatment of GAP
- Ibuprofen for Initial Symptomatic Treatment of Uncomplicated UTI
- Efficacy and Safety of Oral Ciprofloxacin in Management of External Bacterial Otitis
- PROMISE Study: Moxifloxacin, Clinically and Bacteriologically Non-inferior to Ertapenem in Treatment of cIAIs
- OSTRICH: A Short Course of Oral Steroid Treatment not Beneficial over Placebo for Treating Otitis Media with Effusion in Children
- BLISS Study: Continuous Administration of Beta-lactams Associated with Higher Clinical Cure Rates and Better PK/PD Target Attainment Compared to Intermittent Bolus Dosing
- Absence of Pyuria does not Rule out UTI in Children
Patient Education
Clinical Tools
- Patient Screening Questionnaire and Information for Health Care Professionals on Live Attenuated Influenza Vaccine (NASOVAC-S)
- CDC Recommendations for Pregnant Women during Zika Virus Outbreak
- Tracing and Reporting of Contacts for Ebola Virus Disease: Provisional Recommendations
- Ebola Virus Disease: Recommendations on Collection, Storage and Transportation of Samples from Suspected Cases
Guidelines
- IDSA: Guidance on the Treatment of Antimicrobial Resistant Gram-Negative Infections (2020)
- ICMR: Treatment Guidelines for Antimicrobial Use in Common Syndromes (2019)
- IAP Guidebook on Immunization (2018–2019)
- ACG Practice Guideline: Evaluation of Abnormal Liver Chemistries (2017)
- NCDC: National Treatment Guidelines for Antimicrobial Use in Infectious Diseases (2016)
- CDC: Updated Zika Recommendations: Interim Guidance for the Prevention of Sexually Transmitted Zika Virus (July, 2016)
- WHO: Guidelines for the Treatment of Malaria. Third Edition (2015)
- CDC: Guidelines for the Prevention of Intravascular Catheter-Related Infections (2011)
- IDSA: Clinical Practice Guidelines for the Management of Cryptococcal Disease (2010)
Our Publications
Key Trials
- High Rates of Clinical Recovery with Remdesivir in Pregnant Women Hospitalized with Severe COVID-19
- Does Remdesivir Provide a Benefit on Clinical Status for Patients Hospitalized with Moderate COVID-19 Pneumonia?
- Remdesivir Improves Survival Outcomes in ICU Patients with COVID-19 under Mechanical Ventilation
- Efficacy and Safety of Remdesivir 5 Days Course verses 10 Days Course in Treatment of Patients with Severe Covid-19 Disease
- Remdesivir Shortens Time to Recovery in Patients Hospitalized with COVID-19
- Compassionate Use of Remdesivir to Treat Patients with Severe Covid-19
- Early Intervention with Remdesivir Associated with Clinical Improvement in Severe COVID-19 Patients
Patient Education
Clinical Tools
Webcasts
Expert's Viewpoint
- Webinar Snippet: What Precautions Need To Be Taken By Patients Taking Nebulization At Home?
- Webinar Snippet: Is It Appropriate To Share The Nebulizer In This Current Pandemic?
- Webinar Snippet: What Are The Patient Profiles For Nebulization In Current Pandemic?
- Webinar Snippet: Do All Nebulizers Have Equal Risk For Spreading Virus In Current Pandemic?
- Webinar Snippet: What Precautions Need To Be Taken While Nebulizing A Patient In Clinic Settings?
- Webinar Snippet: Is There Any Case-Study To Prove That Infection Risk Is Not Due To Nebulization?
- Webinar Snippet: What Recommendations Did CDC And BTS/NICE Made Concerning The Spread Of Infection Via Nebulizer In This Pandemic?
- Webinar Snippet: Is It Safe To Do Nebulization In Current Pandemic Era?
- Webinar Snippet: What Is The Infection Risk Involved With Nebulizers For Spreading The Virus To HCW Or Bystanders?
Our Publications
Webcasts
- Management of Urinary Tract Infection in Women
- Differential Diagnoses & Medical Management of LUTS During Scenario of Social Distancing
- Dealing with Complicated UTI to Urosepsis in the era of Antibiotic Resistance: Case based Discussion on role of Ceftriaxone Sulbactam EDTA
- Medical Treatment Algorithms for OAB
- Fosfomycin: The Promising Antibiotic Therapy in the Management of UTI
- BPH & Comorbidities
Expert's Viewpoint
- Webinar Snippet: Standard Management Protocol (Antibiotics/Prophylaxis/ Vaccine/Probiotics) & Cases Where Surgical Management is Needed
- Webinar Snippet: UTI in Diabetic Women - Case Illustrations
- Webinar Snippet: Assessment of UTI In Elderly Women
- Webinar Snippet: UTI in Elderly Women (Aging & Urinary Tract)
- Webinar Snippet: Pathophysiology & Predisposing Factors for UTI in Elderly Women
- Webinar Snippet: Fosfomycin in UTI – MOA, Dosage, Advantages & Place in Therapy
- Webinar Snippet: UTI & Its Recurrence in Pregnancy
- Webinar Snippet: Non-antibiotic Strategies for Prevention of UTI In Adolescent Girls and Females of Reproductive Age
- Webinar Snippet: Choosing an Antibiotic Treatment in Acute Uncomplicated Cystitis & Recurrent UTI In Adolescent Girls and Females of Reproductive Age
- Webinar Snippet: Acute Uncomplicated Cystitis in Adolescent Girls and Females of Reproductive Age – Diagnosis (History, Urine Analysis & Special Investigations)
- Management of Complicated UTI – A Case Discussion (Case 2)
- Management of Complicated UTI – A Case Discussion (Case 3)
- Management of Complicated UTI – A Case Discussion
Our Publications
Key Trials
- Swiss Trial: Comparison of Diclofenac versus Norfloxacin in Women with Uncomplicated Lower UTI
- Efficacy, Safety and Cognitive Effects of Solifenacin in Elderly
- TANGO I Trial: Meropenem-Vaborbactam vs Piperacillin-Tazobactam for Treatment of Complicated Urinary Tract Infection
- Vibegron Significantly Reduces Urgency Urinary Incontinence in Overactive Bladder
- Ibuprofen for Initial Symptomatic Treatment of Uncomplicated UTI
- L-Carnitine and L-Acetylcarnitine, Beneficial in Men with Idiopathic Oligoasthenozoospermia
- Safety and Efficacy of Tadalafil Combined with α-Blocker in Benign Prostatic Hyperplasia Patients with Erectile Dysfunction
- Absence of Pyuria does not Rule out UTI in Children
.jpg)
Webcasts
Our Publications
Webcasts
- Expectations of Doctors from Consumer Forum & Guidelines of Supreme Court While Handling the Medico-legal Cases
- Telemedicine: A New Forward
- Medicolegal Issues: Practical Aspects for General Practitioner (GPs)
- Tele-Medicine: Perspectives & Practices
- Common Medico-Legal Concerns for Orthopaedicians
- Medicolegal Issues in Urology: The Risk Management (Panel Discussion)
Webcasts
Our Publications
Key Trials
Patient Education
Clinical Tools
Guidelines
- Endocrine Society: Pharmacological Management of Osteoporosis in Postmenopausal Women: An Endocrine Society Clinical Practice Guideline (2019)
- ACR: American College of Rheumatology/Arthritis Foundation Guideline for the Management of Osteoarthritis of the Hand, Hip, and Knee (2019)
- ACP: Noninvasive Treatments for Acute, Subacute, and Chronic Low Back Pain: Clinical Practice Guideline (2017)
- ACP: Guidelines for Treatment of Low Bone Density or Osteoporosis in Men and Women (2017)
- EULAR: Recommendations for Early Arthritis Management (2016)
- EULAR/EFORT: Recommendations for Fragility Fracture Management in Patients Older Than 50 Years and Prevention of Subsequent Fractures (2016)
- NOF: Clinician’s Guide for the Management of Osteoporosis (2014)
- NOF: Guidelines on Management of Osteoporosis (2014)
Expert's Viewpoint
Key Trials
- Long-Term Maternal Use of Acetaminophen during Pregnancy Increases the Risk of ADHD in Offspring
- Vitamin B12 May Reduce the Rate of Brain Volume Loss in Older People without Dementia
- ARIC Study: Migraine with Visual Aura - An Isolated Risk Factor for Cardioembolic Ischemic Stroke in Late-Middle-Aged Individuals
Patient Education
Guidelines
- NICE: Diagnosis and Initial Management of Stroke and TIA (2019)
- AHA/ASA: Early Management of Patients with Acute Ischemic Stroke - An Update (2019)
- AAN & AHS: Guidelines for the Pharmacologic Prevention of Episodic Migraine in Adults: An Update (2019)
- AHS: Position Statement on Integrating New Migraine Treatment into Clinical Practice (2019)
- ESC: Management of Depression in Coronary Heart Disease Patients-Position Statement (2018)
- AHA/ASA: Early Management of Patients with Acute Ischemic Stroke (2018)
- AHA: Implementation of Telehealth in Cardiovascular and Stroke Care (2016)
- Clinical Practice Guidelines and Principles of Care for People with Dementia (2016)
- AHA/ASA: Guidelines for the Primary Prevention of Stroke (2014)
- NICE: Diagnosis and Management of Depression in Children and Young People (2005)
Webcasts
- After the Storm: Post-CoVID Complications
- Shifting Gears in the Management of Rare Lung Diseases
- A Breath of Fresh Air in OAD: Can Simpler Delivery Platforms Help Reduce Risk of Exacerbations?
- Why is My COPD Patient Not Responding to Standard Treatments?
- Diagnosis and Monitoring of Asthma and COPD in the Era of Social Distancing
- Evolving Role of Anti-Virals in Mild to Moderate COVID-19
- Newer Paradigms in COPD Management
- REMDESIVIR: Evidence to Experience
- Respiratory Crosstalks: Exploring the Cardiopulmonary Link
- Reimagining Good Nebulization Practices in the Current Era
- ICS LABA in Pediatric Asthma
- Aerosol Generating Procedures and Nebulizer Use in the Current Era
- Refining the Choice of ICS in OAD Management
- OAD Management: Spotlight on Patient-centered Care
- Home Nebulization: Current and Future Aspects (Panel Discussion)
- Aerosol Therapy for Asthma – Time for a Relook
- COPD beyond drugs – The Vital Role of Pulmonary Rehabilitation
- Allergies and Asthma
- Novel Approach for Uncontrolled Asthma Management
- Important New Asthma Recommendation for Primary Care Physicians
- FAQs on Pediatric Asthma (2019)
- Nebulization: Altogether Better for Acute Asthma (June 2018; Dr. Suryakant Tripathi)
- Management of Complicated Parapneumonic Effusion: A Physician’s Perspective
- FAQs on Pediatric Asthma (2018)
- From Sneeze to Wheeze – A Case Guided Discussion
- Expert Views on GINA Guidelines - Step Wise Approach on Pediatric Asthma
- ARDS - What to Do and What Not to Do?
- Full Support for a Flourishing Asthma Practice
- Pulmonary Practice for Medicine PGs: Importance, Need & Scope
- Asthma Management: Beyond the Horizon
- Asthma Exacerbation in Children: Re-visiting Basics
- Asthma Management beyond Prescription
- Good Nebulization Practice (2015)
- Asthma Management: What Lies Ahead
- Asthma Diagnosis and Management (in Hindi)
- Improving Outcomes... Earlier the Better in COPD
- Demystifying Nebulization
- Protecting Yourself (and your Patients) from Airborne Pathogens
- Recurrent Pneumonia - Evaluation and Management
- PURVIEW – Community Acquired Pneumonia
- Approach to Fever with Progressive Respiratory Distress
- Nebulization: Altogether Better for Acute Asthma (Webcast in Hindi)
- Early Intervention in the Clinical Course of COPD - The Sooner the Better
- Managing Refractory Cough
- Helping You Deliver in Your Asthma Practice
- Why Asthma is Good for Your Practice
- Approaching an Elderly Patient with Breathlessness
- Management of Tuberculosis
- PURVIEW - Hospital Acquired Pneumonia
- Approach to Unilateral Pleural Effusion
- How Modern Imaging is Changing Pulmonary Medicine Practice
- Preparing for Air Travel: Overcoming Problems in Patients with Chronic Respiratory Disease
Expert's Viewpoint
- Take Home Messages from Guideline Recommendations
- Precautions for Patient on Home Nebulization
- Patient Criteria for Home Maintenance Nebulization
- Webinar Snippet: What Precautions Need To Be Taken By Patients Taking Nebulization At Home?
- Webinar Snippet: Is It Appropriate To Share The Nebulizer In This Current Pandemic?
- Webinar Snippet: What Are The Patient Profiles For Nebulization In Current Pandemic?
- Webinar Snippet: Do All Nebulizers Have Equal Risk For Spreading Virus In Current Pandemic?
- Webinar Snippet: What Precautions Need To Be Taken While Nebulizing A Patient In Clinic Settings?
- Webinar Snippet: Is There Any Case-Study To Prove That Infection Risk Is Not Due To Nebulization?
- Webinar Snippet: What Recommendations Did CDC And BTS/NICE Made Concerning The Spread Of Infection Via Nebulizer In This Pandemic?
- Webinar Snippet: Is It Safe To Do Nebulization In Current Pandemic Era?
- Webinar Snippet: What Is The Infection Risk Involved With Nebulizers For Spreading The Virus To HCW Or Bystanders?
- Webinar Snippet: Where Would You Use Ciclesonide in the Management of Asthma?
- Webinar Snippet: Extra Fine Versus Non Extrafine Formulation in Obstructive Lung Disease: Is There an Advantage?
- Webinar Snippet: What Are the Advantages of Ciclesonide?
- Webinar Snippet: Add-on Extra Fine Ciclesonide in Patients with Poorly Controlled Asthma
- Webinar Snippet: Advantages of Add-on Ciclesonide in Difficult to Treat Asthmatics
- Webinar Snippet: PK/PD Considerations While Choosing ICS
- Webinar Snippet: Clinical Considerations While Choosing ICS
- Managing Acute Asthma with pMDI + Spacer in Real Life
- Webinar Snippet: Changing mindset – Rethinking pMDI+Spacer Usage
- Webinar Snippet: Current Recommendations on Inhaler Devices to Reduce Risk of Infection
- Webinar Snippet: Is pMDI+Spacer Equivalent to Nebulizer?
- Webinar Snippet: Does Every Child with Exacerbation Require a Nebulizer?
- Webinar Snippet: Alternative Management of Acute Exacerbations for Adult OAD Patients
- Practicing Peak Flow Meter as A Home Monitoring Tool
- Webinar Snippet: Switching to Extra -Fine Particle Formulations – Does it Help Improve Asthma Control?
- Webinar Snippet: Switching to BAIs – Option to Consider in Patients with Uncontrolled Asthma
- Webinar Snippet: Choosing the Right Biologic in Severe Asthma
- Webinar Snippet: Role of Omalizumab in Severe Asthma – Selecting the Right Patient
- Webinar Snippet: Choosing the Right Patient for Biologic Therapy
- Webinar Snippet: Diagnosing Severe Asthma
- Differential Diagnosis of Cough
- Respiratory Sounds
- Allergic Rhinitis and Asthma: One Airway, One Disease
- Allergic Rhinitis: Practical Considerations
- Secrets of a Successful Asthma Practice
- The Joy of Treating Asthma
- Asthma: A Growing Burden
Our Publications
- Emzumab (Omalizumab) Monograph
- Favipiravir: Frequently Asked Questions
- Ciplenza (Favipiravir) Monograph
- Ciclohale (Ciclesonide) Product Monograph
- Foracort Synchrobreathe (Formoterol fumarate dihydrate and Budesonide) Infoguide
- Asthma Management in The Acute Setting: Role of pMDI + Spacer
- A Clinician’s Guide
- Aerosol Therapy for Obstructive Airways Diseases: Focus on pMDI+Spacer
- Billargic (Bilastine Oral Solution) Monograph
- Are You Prescribing the Correct Inhalation Device?
- Incorrect Inhaler Techniques: A Perpetual Challenge!
- How to Help Patients Optimise Their Inhaler Technique?
- Seroflo (Salmeterol + Fluticasone propionate) Multi-haler Monograph
- Flohale (Fluticasone Propionate) 50 mcg Inhaler: Datasheet
- Complementing COPD Management Through Smoking Cessation
- Pulmonary Rehabilitation - An Insight
- Inhaled Drug Delivery Systems
- Severe Asthma: A Clinician’s Guide
- Optimizing Inhaled Drug Delivery – Focus on Spacers
- Optimizing Inhaled Drug Delivery: Focus on Dry Powder Inhalers
- Air Pollution: Should We Care About the Air We Breathe?
- Inhalation Devices: Guide for Paramedics
- Asthma – Answers to Clinical Questions (Volume 2)
- Asthma – Answers to Clinical Questions (Volume 1)
- Nebula - A Refresher for Nurses
- IDSA Clinical Practice Guidelines for Acute Bacterial Rhinosinusitis in Adults
- H1N1: Guidance for Clinicians & Public Health Professionals
Our Research
- Comparison of In-vitro Performance of Huf Puf Kit© with Transpacer VM
- Evaluation of the Demographics, Diagnosis and Monitoring, Management, Device Usage and Adherence Among COPD Patients: A Survey of Doctors in Nepal
- Doctors’ Perception of Diagnosis and Management of Asthma in Malaysia: A Survey of Doctors
Key Trials
- Safety Profile of As-needed Budesonide-Formoterol Comparable to Daily Budesonide in Mild Asthma
- Efficacy of Early Azithromycin Administration in Prevention of Severe LRTI in Children
- Fluticasone + Azelastine Nasal Spray Provides Significant Symptom Relief in Allergic Rhinitis
- High Rates of Clinical Recovery with Remdesivir in Pregnant Women Hospitalized with Severe COVID-19
- Does Remdesivir Provide a Benefit on Clinical Status for Patients Hospitalized with Moderate COVID-19 Pneumonia?
- Remdesivir Improves Survival Outcomes in ICU Patients with COVID-19 under Mechanical Ventilation
- Omalizumab Improves Lung Function and Reduces Eosinophils in Adolescents with Allergic Asthma
- Rapid Onset of Action of Azelastine hydrochloride and Fluticasone propionate Combination Nasal Spray
- Efficacy and Safety of Remdesivir 5 Days Course verses 10 Days Course in Treatment of Patients with Severe Covid-19 Disease
- Compassionate Use of Remdesivir to Treat Patients with Severe Covid-19
- Early Intervention with Remdesivir Associated with Clinical Improvement in Severe COVID-19 Patients
- Higher Efficacy and Drug Adherence with Ciclesonide as Step-Down Therapy than Budesonide in Mild to Moderate Asthma
- Improved Lung Function Parameters with Combination of Salmeterol / Fluticasone in Treatment of Bronchial Asthma: An Open Label, Multicentre, Non-Comparative Study
- Efficacy and Superiority of Intranasal Azelastine and Fluticasone Combination Spray as Compared to Monotherapy in Allergic Rhinitis
- Efficacy of Omalizumab Similar in Severe Allergic Asthmatics Irrespective of the Eosinophilic Counts
- Efficacy of As-Needed Budesonide-Formoterol in Mild Asthma Management
- Better Efficacy to Safety Ratio with Fluticasone Propionate than Beclomethasone Dipropionate and Budesonide in Asthma
- Beclomethasone Dipropionate/Formoterol Extrafine Formulation Ensures High Drug Deposition in the Lungs
- Physicians’ Perception on Patterns of Diagnosing and Managing Asthma: A Survey in Myanmar
- Perception of Doctors about Diagnosis, Management and Facing the Challenges with their Patients with Asthma: An Observation-Based Survey in Nepal
- Budesonide–Formoterol More Effective than SABA Alone in Mild Asthmatic Patients
- As-Needed Budesonide–Formoterol Non-inferior to Maintenance Budesonide in Patients with Mild Asthma
- Evaluation of the Demographics, Diagnosis and Monitoring, Management, Device Usage and Adherence Among COPD Patients: A Survey of Doctors in Nepal
- Doctors’ Perception of Diagnosis and Management of Asthma in Malaysia: A Survey of Doctors
- Efficacy and Safety of Moxifloxacin and Gatifloxacin as Initial TB Treatment
- Maintenance and Reliever Therapy with Budesonide/Formoterol Might Reduce the Rate of Severe Exacerbations in Patients with Persistent Asthma
- Real World Clinical Evaluation of Formoterol/Fluticasone Delivered via Revolizer in Persistent Asthma
- AVICA: A Head-to-Head Comparison of Acetaminophen vs. Ibuprofen in Young Children with Mild Persistent Asthma
- CARAS Survey: Co-existence of Allergic Rhinitis and Asthma in Indian Patients
- POSEIDON: Insight into the Reasons for which the Patients Visit Primary Health-Care Practitioners in India
Patient Education
- Breathing Exercises for COPD
- Find Out If Your Child’s Cough is More than Just a Cough
- Eating Right: Tips for the COPD Patients
- Know about COPD
- Are You Ignoring Your Cough?
- Do’s & Don’ts for Asthma Patients
- Nasal Allergy
- How to use the Inhaler?
- How to use the Revolizer?
- How to use the Rotahaler?
- How to use Zerostat VT™ Spacer?
- When is Cough not just a Cough?
Clinical Tools
Guidelines
- PRIDE: A Practical Guide on the Use of Inhaler Devices for Asthma and COPD (March 2021) by PURE Foundation
- AAP: Prevention and Control of Influenza (2020-2021)
- GOLD: Global Strategy for Prevention, Diagnosis and Management of COPD (2020)
- GINA: Global Initiative for Asthma – Global Strategy for Asthma Management and Prevention: Guideline (2020)
- GINA: Recommendations on Asthma Management (2020 Update)
- GINA: Recommendations About Reliever Medications in Steps 3-5 (2019 Update)
- ARIA: Next Generation Allergic Rhinitis and Its Impact on Asthma (2019)
- NICE Guidelines: Cough (Acute)-Antimicrobial Prescribing (2019)
- GINA: Asthma Management and Prevention (2019)
- GINA: Asthma Management and Prevention (2018)
- GOLD: Global Strategy for Prevention, Diagnosis and Management of COPD (2018)
- Ministry of Health & Family Welfare: Guidelines for the Management of Seasonal Influenza (Swine Flu) (2017)
- GOLD: A Strategy for The Management of COPD (2017)
- ATS/ACCP: Liberation from Mechanical Ventilation in Critically Ill Adults (2016)
- WHO: Updated Treatment Guidelines for Drug-Resistant Tuberculosis (2016)
- NICE: Smoking - Reducing and Preventing Tobacco Use (2015)
- NICE: Smoking – Harm Reduction (2015)
- WHO: Guidelines for the Programmatic Management of Drug-Resistant Tuberculosis (2013)
- NICE: Smoking - Supporting People to Stop (2013)
- IDSA: Clinical Practice Guideline for the Diagnosis and Management of Group A Streptococcal Pharyngitis (2012)
- BTS: Guidelines for the Management of Community Acquired Pneumonia in Children (2011)
- WHO: Guidelines for Treatment of Tuberculosis, Fourth Edition (2010)
- WHO: WHO Policy on TB Infection Control in Health-Care Facilities, Congregate Settings and Households (2009)
- ERS: Defining, Treating and Preventing Hospital Acquired Pneumonia: European Perspective (2009)
- WHO: WHO Policy on TB Infection Control in Health-Care Facilities, Congregate Settings and Households (2009)
- ATS/ IDSA: An Official ATS/ IDSA Statement: Diagnosis, Treatment and Prevention of Non Tuberculous Mycobacterial Diseases (2007)
- ERS: Smoking Cessation in Patients with Respiratory Diseases: A High Priority, Integral Component of Therapy: Task Force Report (2007)
- ERS: The Assessment of Cough: Guidelines (2007)
- ATS/IDSA: Online Supplement-An Official ATS/IDSA Statement: Diagnosis, Treatment, and Prevention of Non Tuberculous Mycobacterial Diseases (2007)
- ATS/IDSA: Management of Adults with Hospital-acquired, Ventilator-associated, and Healthcare-associated Pneumonia (2005)
